Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Komal Medical Launches Direct Dawai for Online Pharmacy in Jaipur
Komal Medical & Provision Store is a familiar and trusted name in Jaipur. The store has a strong presence in the city, not for now, but for many years. It is known for its reliable service and genuine medicine, with an aim for maximum client satisfaction. Daily, hundreds of people buy... - February 28, 2026 - Direct Dawai
Thar Process Unveils New Line of CO2 Bulk Delivery Systems for Any Prep SFC and Pilot Scale SFE Users
Thar has a 35-year history of building automated supercritical systems and operating R&D labs. For many years, Thar also built CO2 delivery systems to make it easier for any client to access CO2 without the inconvenience of CO2 bottles/tanks inside the lab. This automation provides a fast return on investment for company's trying to mitigate labor costs and safety risks. - February 13, 2026 - Thar Process
Bio-Neuroscience 2026 Selects 12 Pioneering Companies to Present at Premier Global Neuroscience Drug Development Summit
Bio-Neuroscience today announced the selection of 12 neuroscience drug development companies to present at Bio-Neuroscience 2026, the premier global gathering of neuroscience innovation leaders, investors, and pharmaceutical executives. The companies were chosen from a competitive international field following rigorous evaluation of their scientific innovation, clinical progress, therapeutic approach, and commercial potential. - February 04, 2026 - Broadreach Global LLC
I Holland Celebrates 80 Years of Excellence with a Global Series of Free Seminars
In 2026, I Holland proudly reaches an exciting milestone: 80 years of excellence in tablet compression tooling. Founded in 1946, I Holland has spent eight decades advancing tablet compression technology, sharing industry-leading expertise, and supporting customers around the world. To celebrate... - January 29, 2026 - I Holland Ltd.
INTERPHEX WEEK TOKYO 2026 Expands Pharma Innovation with CMO/CDMO Expo
INTERPHEX WEEK TOKYO, Japan’s largest pharmaceutical and biotech show, will take place from May 20 to 22, 2026, at Makuhari Messe, bringing together a comprehensive range of products and services related to pharmaceuticals and regenerative medicine, and is expected to attract approximately... - January 14, 2026 - RX
CanVeer Biopharma Launches Validation Program for Flagship Neonatal Therapeutic and Appoints Executive Team
CanVeer announces the launch of the validation program for its flagship product, AlveoShield™ (Investigational New Drug). The program targets preterm newborns with or at risk of developing bronchopulmonary dysplasia (BPD). Bronchopulmonary dysplasia is a chronic respiratory disease affecting preterm neonates who require assisted ventilation. AlveoShield™ is designed to potentially prevent and treat BPD. CanVeer also announces the appointment of Sherif Louis as CEO and Behzad Yeganeh as CSO. - January 13, 2026 - CanVeer Biopharma Inc.
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida’s Fastest-Growing Healthcare Corridor
Pharmacy XD LLC, a fully licensed Florida Department of Health–approved national mail order pharmacy and distribution facility, today officially announces its direct-to-patient (DTP) platform. Positioned in the heart of one of Florida’s most dynamic healthcare and life sciences... - January 08, 2026 - Pharmacy XD LLC
Cumberland Biotherapeutics Announces U.S. Launch of FDA Cleared DentoClude F, Complimentary Practice Program, and New Investor Fundraising Initiative
Cumberland Biotherapeutics, LLC, a dental innovation company integrating advanced bioactive glass with botanicals, today announced the U.S. launch of DentoClude F; DentoClude F is marketed under a commercial name for the Occlude® F Dentin Tubule Agent, which received FDA 510(k) clearance under... - December 30, 2025 - Cumberland Biotherapeutics, Inc
Biostem Pharma Private Limited Becomes a Preferred Partner for Third-Party Pharma Manufacturing in India
Biostem Pharma Private Limited strengthens its position as a preferred partner for third-party pharma manufacturing in India. The company offers WHO-GMP-compliant production of tablets, capsules, syrups, and topical formulations, catering to both startups and established pharma brands. - December 29, 2025 - Biostem Pharma Pvt Ltd
Curasia Medilabs Private Limited Offers Monopoly-Based PCD Pharma Franchise Opportunities
Curasia Medilabs Private Limited announces monopoly-based PCD pharma franchise opportunities, offering exclusive territories, a diversified product range, and structured partner support across India. - December 27, 2025 - Curasia Medilabs Pvt. Ltd.
Orange Biotech Launches Innovative Third-Party Pharma Manufacturing Platform to Empower Indian Pharma Brands
Orange Biotech has launched an advanced Third-Party Pharma Manufacturing platform aimed at helping pharma companies, startups, and PCD franchise owners manufacture high-quality formulations efficiently. The platform offers WHO-GMP compliant production, customized product development, regulatory assistance, and pan-India distribution support, strengthening Orange Biotech’s position as a trusted B2B pharma solutions provider. - December 24, 2025 - Orange Biotech Pvt. Ltd.
Lead the Future of Pharma and Biotech: Exhibit at RX Japan's INTERPHEX WEEK TOKYO 2026
INTERPHEX WEEK TOKYO, Asia’s leading comprehensive exhibition for the pharmaceutical and biotech industry, will return to Makuhari Messe on May 20–22, 2026, with exhibitor applications now open, offering an exceptional opportunity for companies to showcase their innovations and connect... - December 11, 2025 - RX
Texas Functional Health Centers Expands Knowledge with Completion of “Importance of Primitive Movements” Seminar
Texas Functional Health Centers has completed the “Importance of Primitive Movements” Seminar, further expanding our knowledge to better serve patients. This training focused on the foundational movement patterns that influence long-term function and recovery. By bringing these insights into our TRUForm rehabilitation system, we’re equipping patients to heal more effectively and move the way their bodies were designed. - December 05, 2025 - Texas Functional Health Centers
Parvus Therapeutics Reports Positive Phase 1 Results for Lead Autoimmune Treg Therapy, PVT201
PVT201 demonstrated favorable safety, predictable pharmacokinetics, and on-target pharmacodynamic activity in first-in-human study. - November 12, 2025 - Parvus Therapeutics U.S., Inc.
True Marker Pharmaceuticals Hits Another Trust & Credibility Milestone
True Marker Pharmaceuticals, Inc., a licensed pharmaceutical wholesaler and repackager based in Phoenix, has earned BBB Accreditation, recognizing its commitment to ethical business practices, transparency, and regulatory compliance. The achievement aligns with True Marker’s expanding U.S. distribution network and reinforces its reputation as a trusted, DSCSA-compliant partner to independent pharmacies and healthcare providers nationwide. - October 28, 2025 - True Marker Pharmaceuticals, Inc.
New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs
Life Science Strategy Group’s Preclinical Services Landscape and CRO Benchmarking Assessment Delivers Data-Driven Insights on Budgets, Outsourcing, Vendor Preferences, and Industry Shifts - October 16, 2025 - Life Science Strategy Group, LLC
Award-Winning AI Simulation Transforms UTI Education; Iridium CE Wins Silver at 20th Annual w3 Awards for Innovation in Medical Learning Experiences
Iridium CE, in partnership with Global Education Group, has won a Silver w3 Award for its AI-powered UTI education program, Rethinking Uncomplicated UTIs. The interactive simulation enables HCPs to diagnose and treat virtual patients in real-time, improving competence, confidence, and antibiotic stewardship. With 1,500+ learners reached and strong outcomes, this marks the program’s second major award. Supported by an educational grant from GSK. - October 10, 2025 - Iridium CE
Aquaterra Biotech Launches Integrated DNA-to-GMP CDMO Platform in Québec
Aquaterra Biotech Launches Integrated Microbial CDMO Platform from DNA Design to GMP Release Aquaterra Biotech announced an integrated contract development and manufacturing (CDMO) platform that advances microbial and recombinant programs from DNA design to GMP release and logistics. Headquartered... - September 30, 2025 - Aquaterra Biotech
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
BioSensics Awarded $5.2M NIH Grant to Advance Digital Biomarkers for PSP and DLB
BioSensics has received a 5-year/$5.2 million grant from the National Institutes of Health (NIH) to develop and validate novel digital biomarkers of disease activity in progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). This 5-year project will leverage BioSensics’ expertise in wearable sensors and digital health technologies and involve close collaboration with leading CurePSP Centers of Care and patient advocacy groups. - September 17, 2025 - BioSensics LLC
Lyfe RX Launches New Brand Identity, Bringing Science-Backed Wellness Solutions to Consumers Nationwide
Lyfe RX, formerly Live Well RX, announces its official rebrand and launch, introducing a fresh identity and expanded wellness offerings. With personalized weight management, peptide therapies, doctor-curated supplements, and high-protein meal prep, Lyfe RX delivers comprehensive, science-backed solutions to help customers achieve their health, longevity, and wellness goals. - September 10, 2025 - The Lyfe RX
BrainWorks Behavioral Health Expands Psychological and Neuropsychological Services to Los Angeles & Orange Counties with New Los Angeles, Whittier and Irvine Offices
BrainWorks Behavioral Health has expanded into Los Angeles and Orange Counties with new offices in Los Angeles, Whittier, and Irvine. The clinics provide autism testing, ADHD evaluations, therapy, and counseling for children, teens, and adults. For over a decade, BrainWorks has delivered compassionate care across Southern California, now bringing necessary psychological and neuropsychological services to more families. - August 27, 2025 - BrainWorks Behavioral Health
Aptitude Health Acquires UK-Based Creative Agency Hug Advertising
Aptitude Health today announced the acquisition of Hug Advertising, a UK-based creative agency renowned for its expertise in branding, animation, and advertising. - August 06, 2025 - Aptitude Health
Global Multiple Myeloma Therapeutics Market and Forecast to 2030
Apelo Consulting has released a report on Global Multiple Myeloma Therapeutics Market (By Disease, Treatment, Route of Administration, End User, Regional Analysis), Company Profiles, Market Dynamics and Recent Developments – Forecast to 2030. - July 31, 2025 - Apelo Consulting Pvt. Ltd.
GENINVO Celebrates 8 Years of Innovation and Growth in the Life Sciences Industry
GENINVO, a leading provider of transformative digital solutions for the life sciences sector, proudly celebrates its 8th anniversary—a journey marked by innovation, collaboration, and impactful contributions across global healthcare and pharmaceutical domains. From a vision sparked eight... - July 22, 2025 - GenInvo, Inc.
Medspartner Offers UK Cancer and Rare Disease Patients a Legal Pathway to Affordable Medications Not Covered by the NHS
Medspartner supports UK cancer and rare disease patients in accessing affordable medications through legal personal importation when NHS options are unavailable or costly. - July 22, 2025 - Medspartner
ALS Network Selects TrialX to Power Its First AI-Based Clinical Trial Finder for the ALS Community
The ALS Network, a mission-driven organization committed to advancing treatments and improving quality of life for people living with amyotrophic lateral sclerosis (ALS), has launched its first AI-based clinical trial finder—powered by TrialX—to help individuals and families affected by ALS access personalized, up-to-date information about clinical trials. - July 18, 2025 - TrialX
Aphora Health Acquires CareNexis to Accelerate Innovation in Specialty Pharmacy Benefits and AI-Driven Insights for Self-Insured Employers
Aphora Health, a leading provider of cost containment solutions and advanced pharmacy benefit strategies for self-insured employers, announces the acquisition of CareNexis, a digital health company known for its proprietary consumer health intelligence and engagement platform. This acquisition... - July 10, 2025 - Aphora Health
Alera Bio Launches to Advance Breakthrough Therapies for Rare Neurological Disorders
Chicago-based Alera Bio has launched with a mission to develop treatments for ultra-rare and neglected neurological disorders, especially in children. Combining scientific innovation with patient urgency, the company will pursue both novel and repurposed therapies via orphan drug and 505(b)(2) pathways. With a lean, capital-efficient model, Alera Bio aims to rapidly advance therapies that address critical gaps in care. - July 03, 2025 - Alera Bio
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world. - June 24, 2025 - ALS Therapy Development Institute
Anzor Pharmaceuticals to Present at Chronic Kidney Disease Conference
Fibroblast growth factor technology constitutes a significant breakthrough in the treatment of metabolic and cancer-related diseases. - June 03, 2025 - Anzor Pharmaceuticals
Vetirus Pharmaceuticals Acquires Enso Discoveries to Expand Regenerative Medicine Portfolio
Vetirus Pharmaceuticals, a multinational company headquartered in Naples, Florida, and London, UK, announced its acquisition of Enso Discoveries, LLC, a Manhattan, Kansas-based biotech company specializing in regenerative medicine. The acquisition was revealed at the 10th annual Animal Health, Nutrition, and Technology Innovation Europe. - April 30, 2025 - Vetirus Animal Health
Pennington Biomedical Research Center Investigates Tirzepatide's Role in Weight Loss and Metabolic Health
Pennington Biomedical researchers included Dr. Eric Ravussin, Dr. Corby Martin, Dr. Robbie Beyl, Dr. Frank Greenway, and Dr. Guillermo Sanchez-Delgado. - April 26, 2025 - Pennington Biomedical Research Center
GENINVO Announces Its Latest Innovation – Confidential Information Scanner (CIS) Tool
GENINVO, a leading provider of life science technology solutions, is proud to announce the launch of its latest innovation – the Confidential Information Scanner (CIS) Tool. This tool is designed to help organizations identify publicly available company confidential information (CCI) across... - April 12, 2025 - GenInvo, Inc.
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation... - April 01, 2025 - Apeximmune Therapeutics
WENO Exchange e-Prescribing Module Now Available in OpenEMR v7.0.2 and Above
This integration provides OpenEMR users the ability to electronically transmit prescriptions securely and efficiently—without the need for traditional third-party networks. - March 30, 2025 - Weno Exchange LLC
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
RX Korea Pioneering the Future of Biopharma at BIOPLUS-INTERPHEX KOREA 2025 with Specialized Pavilions
BIOPLUS-INTERPHEX KOREA (BIX) 2025 is poised to become the main hub of biopharmaceutical innovation, taking place from October 15-17, 2025, at Coex, Seoul. This event will gather researchers, specialists, and industry leaders from around the globe to explore advancements that are shaping the future... - March 19, 2025 - RX
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
Best Medical Website to be Named by Web Marketing Association in 29th Annual WebAward Competition
The Web Marketing Association is now accepting entries for the 29th annual WebAward Competition, recognizing the best websites of 2025 across 86 industries, including many medical related industries. Judged by industry experts, winners gain valuable feedback, SEO benefits, and global recognition. The entry deadline is May 30, 2025. Don’t miss your chance to showcase your digital excellence—enter today at www.webaward.org. - March 12, 2025 - Web Marketing Association
Trump-Era Administration Drug Development & Outsourcing Impact Report
How Tariffs and RFK Jr.’s HHS Appointment May Shift Drug Development & Outsourcing - February 27, 2025 - Life Science Strategy Group, LLC
Legacy Pharma Inc. SEZC Announces the Acquisition of InterMune, Inc. and the U.S. Rights to Esbriet® from Genentech a Member of the Roche Group
Legacy Pharma Inc. SEZC (“Legacy Pharma” or the “Company”), a specialty pharmaceutical company, announced the completion of the acquisition of InterMune, Inc. (“InterMune”) and the intellectual property rights to Esbriet® (pirfenidone) in the United States... - February 06, 2025 - Legacy Pharma Inc. SEZC
GalenusRx Partners with Florida Association of ACOs to Enhance Medication Safety and Drive ACO Performance in 2025
The Florida Association of ACOs (FLAACOs) announced that GalenusRx, a leader in precision medication safety analytics and polypharmacy risk management, has joined its network as a business partner. This partnership will connect GalenusRx with ACOs across Florida, equipping them with innovative... - January 29, 2025 - Florida Association of ACOs
Purple Diamond Hosting Exclusive Webinar on Pharmaceutical Packaging Validation and Product Integrity
Purple Diamond, a leading ISO-accredited package testing lab, will host a free webinar on February 4, at 2 pm EST. "Protecting Pharma Integrity: The Science of Packaging Validation" will provide insights into testing methodologies and tools critical for ensuring pharmaceutical packaging safety and compliance. - January 16, 2025 - Purple Diamond Testing
Bench International Celebrates 50 Years of Transforming Life Sciences Leadership
Bench International, the longest-serving woman-founded executive search firm in life sciences, is proud to celebrate its 50th Anniversary, marking five decades of shaping transformative leadership in the industry. This milestone will be commemorated at a special gala event next week in San... - January 10, 2025 - Bench International
Conigen Bioscience and North Star Scientific, Inc. Partner to Broaden Access to Next-Generation Dimeric-Specific Epitope Tool-Molecules, Empowering Drug Discovery
Conigen Bioscience, Inc., based in Worcester, Massachusetts, has partnered with North Star Scientific, Inc. to expand access to its transformative protein tools across North America. Conigen pioneers innovations in bioactive conformational soluble dimer proteins and membrane proteins displayed on... - January 07, 2025 - Conigen Bioscience, Inc
Dr Harte Says: Drug Control, Not Gun Control
The recent Madison, WI school shooting brings the usual cries for gun control, when that is not the point. Legally prescribed psych drugs are making kids crazy and violent. - December 18, 2024 - The Harte of Chiropractic, P.C
Vamstar & Pricia Join Forces to Transform Pricing in the Nordics Pharmaceutical Sector
Vamstar partners with Nordic consultancy Pricia to combine its AI-driven Pricing Co-Pilot with Pricia’s expertise in pricing strategy, support, and turnkey systems, enhancing pharma pricing decisions. - December 12, 2024 - Vamstar
Arizona Pharmacy Association Appoints Garet Turner as New CEO
Today, the Arizona Pharmacy Association (AzPA), the leading voice for Arizona’s pharmacy professionals, announced the appointment of Garet Turner as its new Chief Executive Officer. Turner, a seasoned management, membership and fundraising professional will take the helm on January... - December 07, 2024 - Arizona Pharmacy Association
Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder
Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes, launches a new global AI-based clinical trial finder - powered by TrialX - that aims to increase accessibility of clinical trial information for patients and families affected by pancreatic cancer. - November 19, 2024 - TrialX